QA: Organon Co in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821825_2022_Organon_Co.pdf

Logs

Graph

Absolute values for 0001821825, Organon Co

  xvar xval
0 AssetsCurrent 3,760,000,000
1 IntangibleAssetsNetIncludingGoodwill 5,254,000,000
2 PropertyPlantAndEquipmentNet 973,000,000
3 remainder_Assets 694,000,000
4 LiabilitiesCurrent 2,597,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,382,000,000
8 SellingGeneralAndAdministrativeExpense 1,668,000,000
9 ResearchAndDevelopmentExpense 443,000,000
10 remainder_Expenses 460,000,000
11 remainder_Revenues 6,304,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 98,000,000
  yvar yval
0 Assets 10,681,000,000
1 Liabilities 2,597,000,000
2 Expenses 4,953,000,000
3 Revenues 6,304,000,000
4 StockholdersEquity 8,084,000,000
5 NetIncome 1,351,000,000
6 ComprehensiveNetIncome 1,400,000,000
7 BaseVar 12,316,500,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.87
9 EconomicCapitalRatio 3.60

Edgar->Model Mapping

Feature Distribution